Patents by Inventor James T. Matthews

James T. Matthews has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of making an internal capacitive substrate for use in a circuitized substrate and method of making said circuitized substrate
    Patent number: 7384856
    Abstract: A method of forming a capacitive substrate in which first and second conductors are formed opposite a dielectric, with one of these electrically coupled to a thru-hole connection. Each functions as an electrode for the resulting capacitor. The substrate is then adapted for being incorporated within a larger structure to form a circuitized substrate such as a printed circuit board or a chip carrier. Additional capacitors are also possible.
    Type: Grant
    Filed: July 5, 2005
    Date of Patent: June 10, 2008
    Assignee: Endicott Interconnect Technologies, Inc.
    Inventors: Rabindra N. Das, John M. Lauffer, Voya R. Markovich, James T. Matthews
  • Methods of making neuraminidase-supplemented compositions
    Patent number: 6951649
    Abstract: The present invention relates to a method for formulating a vaccine composition which comprises an anti-influenza vaccine, wherein the improvement of the vaccine composition is that the vaccine includes, as an additive, neuraminidase (NA). The base anti-influenza vaccine can be any commercially available anti-influenza vaccine. The improved composition can include and be administered with an adjuvant. The improved vaccine composition provides protection in a host, animal or human, against influenza infection, including viral replication and systemic infection.
    Type: Grant
    Filed: October 4, 2002
    Date of Patent: October 4, 2005
    Assignee: Protein Sciences Corporation
    Inventors: Gail Eugene Smith, James T. Matthews, Edwin D Kilbourne, Bert E. Johansson, Bethanie E. Wilkinson, Andrie I. Voznesensky, Craig S. Hackett, Franklin Volvovitz
  • Neuraminidase-supplemented compositions
    Publication number: 20030165521
    Abstract: An anti-influenza vaccine composition wherein the improvement is that the vaccine includes, as an additive, neuraminidase (NA). The base anti-influenza vaccine can be any commercially available anti-influenza vaccine. The composition can include and be administered with an adjuvant. The vaccine composition provides protection in a host, animal or human, against influenza infection, including viral replication and systemic infection. Oral, nasal or other mucosal or per needle administration, including intracutaneous, intradermal, intermuscular, intravascular, and intravenous injections, are included.
    Type: Application
    Filed: October 4, 2002
    Publication date: September 4, 2003
    Inventors: Gale Eugene Smith, James T. Matthews, Edwin D. Kilbourne, Bert E. Johansson, Bethanie E. Wilkinson, Andrei I. Voznesensky, Craig S. Hackett, Franklin Volvovitz
  • Neuraminidase-supplemented compositions
    Patent number: 6485729
    Abstract: An anti-influenza vaccine composition wherein the improvement is that the vaccine includes, as an additive, neuraminidase (NA). The base anti-influenza vaccine can be any commercially available anti-influenza vaccine. The composition can include and be administered with an adjuvant. The vaccine composition provides protection in a host, animal or human, against influenza infection, including viral replication and systemic infection. Oral, nasal or other mucosal or per needle administration, including intracutaneous, intradermal, intramuscular, intravascular, and intravenous, are included.
    Type: Grant
    Filed: August 11, 1999
    Date of Patent: November 26, 2002
    Assignee: Protein Sciences Corporation
    Inventors: Gail Eugene Smith, James T. Matthews, Edwin D. Kilbourne, Bert E. Johansson, Bethanie E. Wilkinson, Andrei I. Voznesensky, Craig S. Hackett, Franklin Volvovitz
  • Antiviral peptides
    Patent number: 5859187
    Abstract: Inhibition of UL42 stimulation of herpesvirus DNA polymerase activity is exhibited by novel compounds of the formulasW'--A.sub.1 --A.sub.2 --A.sub.3 --A.sub.4 --A.sub.5 --A.sub.6 --A.sub.7 --A.sub.8 --A.sub.9 --A.sub.10 --A.sub.11 --X ?SEQ. ID NO: 1!andY'--A.sub.12 --A.sub.13 --A.sub.14 --A.sub.15 --A.sub.16 --A.sub.17 --Z ?SEQ. ID NO: 2!that are useful as antiviral agents.
    Type: Grant
    Filed: January 29, 1992
    Date of Patent: January 12, 1999
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: James T. Matthews, Katerina Leftheris, Robert K. Hamatake, John T. Stevens, Mary L. Haffey
  • Selective inhibition of DNA polymerase
    Patent number: 5120639
    Abstract: Two peptides, P6 and P7, having the amino acid sequence APGDEPAPPY and AGATAEETRY have been used to obtain antibodies made against them, which antibodies specifically neutralize HSV-1 and HSV-2 DNA polymerase. The present invention also contemplates a method of screening for inhibitors of HSV-1 and HSV-2 polymerase utilizing the antibodies.
    Type: Grant
    Filed: April 3, 1989
    Date of Patent: June 9, 1992
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Mary L. Haffey, James T. Matthews